Feng Ming Lin
About Feng Ming Lin
Feng Ming Lin is a Senior Scientist and Laboratory Director at CellMax Life in Taipei, Taiwan, with extensive experience in cancer research. He holds a Doctor of Philosophy from National Defense Medical Center and has contributed to various studies and publications related to circulating tumor cells and cancer detection.
Work at CellMax Life
Feng Ming Lin has been employed at CellMax Life since 2015. He currently holds the position of Senior Scientist, a role he has occupied since 2018. In addition, he has served as the Laboratory Director since 2017. His work at CellMax Life is based in Taipei, Taiwan, where he has contributed to advancements in cancer diagnostics and research.
Education and Expertise
Feng Ming Lin earned his Bachelor's degree from Chang Gung University, completing his studies from 1997 to 2001. He continued his education at the National Defense Medical Center, where he obtained his Doctor of Philosophy degree from 2006 to 2010. He also achieved a Master's degree from Chang Gung University from 2001 to 2003. His educational background provides a strong foundation for his research in oncology.
Background
Prior to his current roles at CellMax Life, Feng Ming Lin worked as a Postdoctoral Research Fellow at MD Anderson Cancer Center in Houston, Texas, from 2011 to 2015. His experience in a leading cancer research institution has contributed to his expertise in the field of cancer diagnostics and treatment.
Research Contributions
Feng Ming Lin has made significant contributions to cancer research. He participated in a study presented at the European Society for Medical Oncology regarding a novel blood-based circulating tumor cell biomarker for breast cancer detection. He has also published research in Cancer Immunology, Immunotherapy on a circulating tumor cell-based blood test for non-small cell lung cancer. His involvement in research presented at the AACR Annual Meeting focused on CTC and ctDNA profiling for immunotherapy and targeted therapy selection.
Publications and Presentations
Feng Ming Lin has contributed to various publications in reputable journals. Notably, he was involved in a publication in Biomaterials on an antibody conjugated supported lipid bilayer for capturing tumor cells. Additionally, he participated in a study on circulating tumor cells for colorectal cancer screening, which was presented at the ASCO Gastrointestinal Cancers Symposium.